NCT03376256

Brief Summary

The purpose of this pilot study is to evaluate whether the Compuflo Epidural Instrument injection pump technology, which is FDA approved for lumbar epidural anesthesia, is also capable of identifying the thoracic epidural space through measurement of pressure levels. While this device is approved by the FDA for use in the procedure of the lumbar epidural, it is not used to perform the epidural procedure but rather to measure the epidural pressure. This study will likewise measure the epidural pressure.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jul 2018

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 12, 2017

Completed
6 days until next milestone

First Posted

Study publicly available on registry

December 18, 2017

Completed
7 months until next milestone

Study Start

First participant enrolled

July 11, 2018

Completed
6 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 17, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 17, 2018

Completed
2.4 years until next milestone

Results Posted

Study results publicly available

December 3, 2020

Completed
Last Updated

December 3, 2020

Status Verified

November 1, 2020

Enrollment Period

6 days

First QC Date

December 12, 2017

Results QC Date

November 10, 2020

Last Update Submit

November 10, 2020

Conditions

Keywords

thoracic epiduralpressure measurementdevice

Outcome Measures

Primary Outcomes (1)

  • Pressure Levels in Thoracic Epidural Space

    The Compuflo Epidural Instrument measures the pressure levels in millimeters of mercury (mmHg) in the thoracic epidural space

    Day 1

Secondary Outcomes (1)

  • Percent of Successful Performance of Thoracic Epidural Anesthesia Using Loss of Resistance Technique

    Day 1

Study Arms (2)

Phase A - Thoracic ES with LOR

EXPERIMENTAL

Patients will receive thoracic epidural anesthesia. The thoracic epidural needle will be introduced until loss of resistance (LOR) is perceived to identify the thoracic epidural space (ES). The Compuflo Epidural Instrument will be used to record pressure readings. The thoracic epidural procedure will then continue per standard of care.

Device: Compuflo Epidural Instrument

Phase B - Thoracic ES with Compuflo

EXPERIMENTAL

Patients will receive thoracic epidural anesthesia. The thoracic epidural needle will be introduced until the Compuflo Epidural Instrument indicates that pressure has decreased. The loss of resistance technique will then be used to identify the thoracic epidural space. The thoracic epidural procedure will then continue per standard of care.

Device: Compuflo Epidural Instrument

Interventions

Compuflo Epidural Instrument will be used to measure pressure levels in the thoracic epidural space while performing thoracic epidural anesthesia.

Phase A - Thoracic ES with LORPhase B - Thoracic ES with Compuflo

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 18 to 80 years inclusive
  • BMI 18.5 to 40 inclusive
  • Scheduled for thoracic epidural anesthesia

You may not qualify if:

  • Patients younger than 18 years or older than 80 years of age
  • Patients with BMI less than 18.5 or greater than 40
  • Contraindication to thoracic epidural anesthesia
  • Allergy or hypersensitivity to local anesthetics
  • Patients with preexisting nerve damage
  • Patients unable to provide written informed consent
  • Individuals of vulnerable populations: children, pregnant women, prisoners

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Miami Hospital

Miami, Florida, 33136, United States

Location

Related Publications (8)

  • Leurcharusmee P, Arnuntasupakul V, Chora De La Garza D, Vijitpavan A, Ah-Kye S, Saelao A, Tiyaprasertkul W, Finlayson RJ, Tran DQ. Reliability of Waveform Analysis as an Adjunct to Loss of Resistance for Thoracic Epidural Blocks. Reg Anesth Pain Med. 2015 Nov-Dec;40(6):694-7. doi: 10.1097/AAP.0000000000000313.

    PMID: 26469364BACKGROUND
  • Tsui BC, Gupta S, Finucane B. Confirmation of epidural catheter placement using nerve stimulation. Can J Anaesth. 1998 Jul;45(7):640-4. doi: 10.1007/BF03012093.

    PMID: 9717595BACKGROUND
  • Kuo WC, Kao MC, Chang KY, Teng WN, Tsou MY, Chang Y, Ting CK. Fiber-needle swept-source optical coherence tomography system for the identification of the epidural space in piglets. Anesthesiology. 2015 Mar;122(3):585-94. doi: 10.1097/ALN.0000000000000531.

    PMID: 25437497BACKGROUND
  • Vallejo MC, Phelps AL, Singh S, Orebaugh SL, Sah N. Ultrasound decreases the failed labor epidural rate in resident trainees. Int J Obstet Anesth. 2010 Oct;19(4):373-8. doi: 10.1016/j.ijoa.2010.04.002. Epub 2010 Aug 8.

    PMID: 20696564BACKGROUND
  • Lechner TJ, van Wijk MG, Maas AJ. Clinical results with a new acoustic device to identify the epidural space. Anaesthesia. 2002 Aug;57(8):768-72. doi: 10.1046/j.1365-2044.2002.02621.x.

    PMID: 12133089BACKGROUND
  • Crawford JS. The second thousand epidural blocks in an obstetric hospital practice. Br J Anaesth. 1972 Dec;44(12):1277-87. doi: 10.1093/bja/44.12.1277. No abstract available.

    PMID: 4265424BACKGROUND
  • Thangamuthu A, Russell IF, Purva M. Epidural failure rate using a standardised definition. Int J Obstet Anesth. 2013 Nov;22(4):310-5. doi: 10.1016/j.ijoa.2013.04.013. Epub 2013 Aug 6.

    PMID: 23932551BACKGROUND
  • Ready LB. Acute pain: lessons learned from 25,000 patients. Reg Anesth Pain Med. 1999 Nov-Dec;24(6):499-505. doi: 10.1016/s1098-7339(99)90038-x. No abstract available.

    PMID: 10588551BACKGROUND

Limitations and Caveats

To protect participant privacy and maintain confidentiality, results will not be reported.

Results Point of Contact

Title
Dr. Ralf Gebhard
Organization
University of Miami

Study Officials

  • Ralf E Gebhard, MD

    University of Miami

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Clinical Anesthesiology

Study Record Dates

First Submitted

December 12, 2017

First Posted

December 18, 2017

Study Start

July 11, 2018

Primary Completion

July 17, 2018

Study Completion

July 17, 2018

Last Updated

December 3, 2020

Results First Posted

December 3, 2020

Record last verified: 2020-11

Data Sharing

IPD Sharing
Will not share

Locations